1296271-75-4

Upstream product

• 1296271-66-3 methyl 8-bromo-2-(ethylthio)-4-oxo-4H-chromene-6-carboxylate 
• 372-39-4 3,5-difluoroaniline 
• 160753-84-4 methyl 3-acetyl-5-bromo-4-hydroxybenzoate 
• 57009-12-8 methyl 3-acetyl-4-hydroxybenzoate 
• 71407-98-2 3-acetyl-5-bromo-4-hydroxybenzoic acid 
• 1296271-65-2 methyl 8-bromo-4-hydroxy-2-thioxo-2H-chromene-6-carboxylate 
• 1296271-90-3 C₁₅H₁₅BrO₄S 
• 29415-97-2 methyl 3-bromo-4-hydroxybenzoate 
• 99-76-3 methyl 4-hydroxylbenzoate 

Downstream Products

• 1296271-78-7 8-(1-(3,5-difluorophenylamino)ethyl)-2-((S)-3-methylmorpholino)-4-oxo-4H-chromene-6-carboxylic acid 
• 1296271-77-6 methyl 8-(1-(3,5-difluorophenylamino)ethyl)-2-((S)-3-methylmorpholino)-4-oxo-4H-chromene-6-carboxylate 
• 1296271-76-5 methyl 8-(1-(3,5-difluorophenylamino)ethyl)-2-(ethylsulfinyl)-4-oxo-4H-chromene-6-carboxylate 
• 1296271-32-3 8-(1-(3,5-difluorophenylamino)ethyl)-N,N-dimethyl-2-((S)-3-methylmorpholino)-4-oxo-4H-chromene-6-carboxamide 

Relevant academic research and scientific papers

CHROMENONE DERIVATIVES WITH ANTI-TUMOUR ACTIVITY

The invention concerns chromenone derivatives of Formula (I) or a pharmaceutically-acceptable salts thereof, wherein each of R1, R2, R3, R4, R5, R6, R7, R8, n and R9 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders.

CHROMENONE DERIVATIVES

The invention concerns chromenone derivatives of Formula I or a pharmaceutically-acceptable salts thereof, wherein each of R1, R2, R3, R4, R5, R6, R7, R8, n and R9 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders.